https://clinicaltrials.gov/ct2/show/NCT02437890?type=Intr&cond=Lupus&phase=012345&lupd_s=01%2F23%2F2019&lupd_d=14
Condition : Lupus Erythematosus, Systemic
Interventions : Biological: ALX-0061; Biological: Placebo
Sponsor : Ablynx
Completed
A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus
NCT02437890
Fri, 08 May 2015 12:00:00 EDT
>>> completed and results posted
